The activation of sorghum NADP-malate dehydrogenase is initiated by thiol/disulfide interchanges with reduced thioredoxin followed by the release of the C-terminal autoinhibitory extension and a structural modification shaping the active site into a high efficiency and high affinity for oxaloacetate conformation. In the present study, the role of the active site arginines in the activation and catalysis was investigated by sitedirected mutagenesis and arginyl-specific chemical derivatization using butanedione. Sequence and mass spectrometry analysis were used to identify the chemically modified groups. Taken together, our data reveal the involvement of Arg-134 and Arg-204 in oxaloacetate coordination, suggest an indirect role for Arg-140 in substrate binding and catalysis, and clearly confirm that Arg-87 is implicated in cofactor binding. In contrast with NAD-malate dehydrogenase, no lactate dehydrogenase activity could be promoted by the R134Q mutation. The decreased susceptibility of the activation of the R204K mutant to NADP and its increased sensitivity to the histidine-specific reagent diethylpyrocarbonate indicated that Arg-204 is involved in the locking of the active site. These results are discussed in relation with the recently published NADP-MDH three-dimensional structures and the previously established three-dimensional structures of NAD-malate dehydrogenase and lactate dehydrogenase.
In recent years great progress has been made toward understanding the mechanism of the reductive activation of chloroplastic NADP-dependent malate dehydrogenase (EC 1.1.1.82) by reduced thioredoxin (1) . The activation is the direct consequence of the reduction of specific disulfides located at the Nand C-terminal ends of each monomer of the homodimeric enzyme. In the oxidized form of the enzyme, the C-terminal end is trapped inside the active site cleft, where it acts as an internal inhibitor (2) (3) (4) . It is released upon the thioredoxin-dependent reduction of the disulfide, thus opening the access for substrate oxaloacetate (5) . The reduction of the N-terminal disulfide loosens the interaction between subunits and triggers a conformational change or/and an increased flexibility of the active site toward an improved catalytic efficiency. The catalytic His and Asp residues responsible for the acid-base catalytic mechanism have been identified by site-directed mutagenesis and chemical derivatization (6) , but little is known about the residues binding oxaloacetate and their possible role in the interaction with the C terminus in the oxidized form and in the conformational change of the active site. Sequence alignments with the permanently active NAD-dependent malate dehydrogenases (EC 1.1.1.37) identified three conserved Arg residues potentially involved in oxaloacetate binding (2, 7) . These Arg correspond to Arg-134, -140, and -204 of NADP-MDH 1 (sorghum MDH numbering, Protein Data Bank code 7mdh). The three-dimensional structure of the oxidized enzyme shows these Arg, and particularly Arg-204, to be situated in proximity of the negatively charged C-terminal residues (2, 3) . However, there is no functional evidence so far about the involvement of these residues in blocking of the active site and in catalysis. Mutagenesis studies performed on NAD-MDH showed Arg-81, corresponding to Arg-134 of NADP-MDH, to be responsible for the specificity of the dehydrogenase for oxaloacetate; indeed, its mutation for a Gln, the corresponding residue in lactate dehydrogenases, conferred on the enzyme the ability to use pyruvate, thus transforming it into a bifunctional malate/lactate dehydrogenase (8, 9) . Conversely, lactate dehydrogenase can be converted into a malate dehydrogenase by the mutation of the conserved Gln into an Arg (10) . This point has never been addressed for NADP-MDH. In the present study, we focused on the evaluation of the roles of the conserved Arg of NADP-MDH to address the aforementioned points by using two complementary approaches: chemical derivatization and site-directed mutagenesis.
MATERIALS AND METHODS
Materials-Pfu DNA polymerase. DEAE-Sephacel and Matrex Red A chromatographic supports were from Sigma and Millipore, respectively. The monoQ HR5/5 fast protein liquid chromatography column and the radiolabels were from Amersham Pharmacia Biotech.
The pUC9 and pETmdh vectors described in Refs. 2 and 11 were used in the mutagenesis strategy. Escherichia coli DH5␣ FЈ, from Life Technologies, Inc., was used to produce high yields of pET and pUC vectors. E. coli BL21 (DE3) strain [hsdS gal (c Its 857 ind1 Sam7 nin lacUV5-T7 gene 1)] was used for the production of mutated NADPMDHs encoded by recombinant pET vectors (12) . Bacteria were grown at 37°C on Luria broth medium supplemented with 50 M ampicillin when the bacteria carried pET or pUC plasmid. Recombinant proteins overexpression could also be carried out in minimum media (M9) supplemented with ampicillin 50 M.
Site-directed Mutagenesis of NADP-MDH cDNA and DNA Sequencing-PCR site-directed mutagenesis strategy was used to introduce the R134K, R204K, or R140Q mutations. The following oligonucleotides were used: R134K, CCTTATTGGTGCTAAGCCCAAAGGTCCTG; new pet down, GCCGCCGCCCAGTCCTGCTCGCTTCGCTAC; R204K, * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. GCTTTGAGTGCTAGCTGGCACTTTGCTTTATTTTCATCC; near-up, CACAACGGTTTCCCTCTAGAAATAATTTTG; R140Q, AAAAAGCTA-AGCCCCAGGTCCTGGCATGGAGCAAGCTGCG; pet down, GGCCG-CCGCCCAGTCCTG. Mutagenic bases are in bold. The near-up oligonucleotide hybridizes to the pET plasmid 50 bp from the 5Ј end of the NADP-MDH cDNA. New pet down and pet down hybridize to the pET plasmid 50 bp from the 3Ј end of the NADP-MDH cDNA.
A PCR reaction using the R134K and the new pet down oligonucleotides or the R204K and the near-up oligonucleotides with the vector Petmdh⌬-15 as template gave a 1000-bp and a 750-bp product, respectively. The whole cDNA bearing the R134K mutation was then obtained by exchanging the BamHI-Bpu1102I fragment of wild-type NADP MDH cDNA cloned in pUC9 for the fragment obtained by PCR. The cDNA bearing the R204K mutation was obtained by exchanging the NcoI-NheI fragment of wild-type MDH cDNA cloned in pUC9 for the fragment obtained by PCR. The mutated MDH cDNAs were transferred into a pETmdh⌬-15 vector for production of the modified proteins.
The R140Q and the pet down oligonucleotides with the mdh vector as template gave an 1100-bp PCR product. The whole cDNA bearing the R140Q mutation was then obtained by exchanging the Bpu1102I-NheI fragment of wild-type MDH cDNA cloned in pUC9 for the fragment obtained by PCR. The mutated cDNA was transferred into a pETmdh vector for production of the modified protein. The cDNA sequence was controlled at each cloning step according to the Sanger sequencing method using T7 kit from Amersham Pharmacia Biotech (13) .
Mutated Protein Production and Purification-Procedures for expression of the mutated NADP-MDH cDNA in pET and the preparation of soluble protein extracts from transformed BL21 E. coli were the same procedure as described previously (11) . When minimum medium was used, bacteria were grown as following. An isolated BL21 clone containing the pET vector of interest was grown over the day in 3 ml of M9 minimum medium supplemented with 50 M ampicillin at 37°C and then transferred in 150 ml of M9 minimum medium supplemented with 50 M ampicillin and grown overnight at 37°C. The next day, the 150-ml culture was split into 5 liters of M9 minimum medium, supplemented with 50 M ampicillin and grown at 37°C until A 600 nm ϭ 0.5-0.6. Recombinant protein overexpression was then induced by 100 M isopropyl-1-thio-␤-d-galactopyranoside, and 50 M additional ampicillin was added. The induced culture was grown overnight at 37°C, bacteria were collected and washed, and extract was prepared as described previously (11) . Mutated and recombinant NADP-MDHs were purified by fractionation in ammonium sulfate that was between 35 and 60% saturated in 20 mM sodium phosphate, EDTA 1 mM, pH 7.2 buffer (PE buffer) followed by dialysis overnight against 100 volumes of PE buffer. The fractionated extract was then loaded on a DEAE-Sephacel column (25 ϫ 3 cm), washed extensively with PE buffer, and eluted with a linear gradient (2 ϫ 250 ml) of 0 -0.6 M NaCl in PE buffer. The active fractions were pooled and directly loaded on a Matrex Red A column (15 ϫ 1.5 cm). After washing with PE buffer, the enzyme was eluted from the affinity column with a linear gradient (2 ϫ 250 ml) 0 -3 M NaCl in PE. Fractions enriched in NADP-MDH protein were pooled, dialyzed overnight against 100 volumes PE buffer, and concentrated to 1-1.5 mg/ml on an Amicon ultrafiltration cell using a YM10 membrane. Further purification was performed using MonoQ ion exchange column. After loading the protein, elution was achieved with a 30-min linear gradient of 0 to 100% buffer B for the R204K mutated protein or 30 to 70% buffer B for the R134K-mutated protein (buffer A: 30 mM Tris-HCl, pH 7.9; buffer B: 30 mM Tris-HCl, pH 7.9, 0.5 M NaCl) at a flow rate of 0.5 ml/min. The active fractions were then dialyzed in PE and concentrated to 1 mg/ml on an Amicon Centricon concentrator 30. Their purity was checked by vertical SDS-polyacrylamide gel electrophoresis following the method of Schä gger and von Jagow (14) . The protein bands were visualized by Coomassie Brillant Blue staining. Sorghum NADP-MDH was purified from sorghum leaves as described for corn NADP-MDH purification (15) .
Activation Kinetics, Enzyme Activity Assays, and Kinetic Parameter Determinations-The enzymes were activated by 20 M E. coli thioredoxin reduced by 10 mM DTT at 25°C in 100 mM Tris-HCl, pH 7.9 buffer. Activity was measured on activated aliquots at 30°C by following the decrease in absorbance at 340 nm in a standard assay mixture (1 ml) containing 100 mM Tris-HCl, pH 7.9, 15 mM OAA in the case of the R134K mutant, 5 mM OAA in the case of the R204K mutant protein, or 20 mM OAA in the case of the R140Q protein and 140 M NADPH. The kinetic parameters were determined on preactivated enzymes by varying the concentration of each substrate in the assay mixture.
Butanedione Assays-The NADP-malate dehydrogenase inactivation assays using butanedione were performed in 0.1 M borate/boric acid, pH 7.2, buffer because borate was previously shown to stabilize this modification (16, 17) . Sorghum MDH was preactivated using 1 or 10 mM DTT and 20 M thioredoxins at 25°C for 20 min and then diluted, respectively, 4 or 2 times in a 0.1 M borate/boric acid buffer pH 7.2, containing a selected butanedione concentration. This inactivation mixture was incubated at 25°C. The reactions were carried out in the dark to avoid possible photoactivation of butanedione, which could enhance nonspecific reactions with other groups than arginyl (17) . Fractions were assayed for activity at incubation times up to 30 min. Protection experiments against sorghum NADP malate dehydrogenase inactivation by butanedione have been carried out with 1 or 12 mM NADPH, AMP, or nicotinamide added before 4 mM butanedione in the inactivation mixture.
Identification of Modified Residues -Sorghum NADP-MDH (10-nmol monomer) was preactivated using 10 mM DTT, 20 M thioredoxins in 0.1 M borate/boric acid, pH 7.2, buffer at 25°C for 20 min. Half of the activated mixture was treated using 10 mM butanedione in 0.1 M borate/ boric acid buffer, pH 7.2 (dilution 2 of the activated mixture) for 30 min at 25°C. The other half of the mixture was treated without butanedione as a control. The two samples were then subjected to MonoQ anion exchange chromatography to remove thioredoxins and excess reagent. Elution was performed using 0 -0.5 M NaCl gradient in 20 mM borate/ boric acid, pH 7.2, buffer for 30 min with a 0.5 ml/min flow rate. Fractions containing NADP-MDH were dialyzed against 0.2 M borate/ boric acid, pH 8.3 buffer. The activity and the amount of protein were measured. Tryptic digestion was then carried out using 1 g of trypsin for 50 g of MDH for 7 h at 37°C. Peptides were separated by reverse phase HPLC using a Vydac C 18 300-Å column (4.6 ϫ 150 mm). Elution was performed with a linear gradient from 0 to 80% acetonitrile in 0.1% trifluoroacetic acid over 90 min at a flow rate of 1 ml/min. Absorbancy was recorded at 215 and 280 nm. Selected peptides were further analyzed by N-terminal sequencing using an Applied Biosystem 473A protein sequencer and MALDI-TOF mass spectrometry.
Catalytic Histidine Modification by DEPC-The active site accessibility can be tested using DEPC, which specifically interacts with the catalytic histidine (6) . The catalytic histidine modification is monitored by the loss of enzyme activity. Oxidized mutated or wild-type MDHs were incubated in 50 mM phosphate buffer, pH 6.8, containing 1 mM DEPC for 5 min at 25°C. The enzymes were then activated by the addition of 4 volumes of activation medium consisting of 20 M thioredoxin and 10 mM DTT (final concentrations) in 100 mM Tris-HCl buffer, pH 7.9. The 5-fold dilution and raise in pH stopped the reaction with DEPC. Activation kinetics were then followed by measuring MDH activity on aliquots taken out at regular time intervals.
RESULTS

R204K-, R134K-, and R140Q-mutated Proteins Are Altered in Their Substrate
Binding and Catalytic Efficiencies-Arginine residues at positions 134, 140, and 204 of sorghum NADP-MDH were mutated into glutamines. The R140Q-mutated protein was the only one exhibiting some activity upon activation, whereas the R204Q and the R134Q mutants remained inactive. The R140Q mutant exhibited a 30-fold increase in the K m OAA value and a 375-fold decrease in the k cat value compared with the wild type enzyme (Table I) . To get further information about the roles of Arg-134 and Arg-204 in substrate binding and catalysis, new mutated proteins in which arginine 204 or 134 were replaced by lysines have been engineered. Both R134K-and R204K-mutated proteins were weakly active after preactivation; they exhibited a 100-fold increase in K m values for oxaloacetate and, respectively, a 270-fold and a 30-fold decrease in k cat values compared with the wild-type NADP-MDH (table I) . In all cases, the overall catalytic efficiencies (k cat /(K m NADPH ϫ K m OAA)) were strikingly affected by the mutations (by a 10 4 -fold factor). These results suggest a role of these residues in substrate binding and catalysis. To discriminate between the reactivities of active site arginyl residues, arginyl-specific chemical modification experiments were performed, and modified residues were identified.
Butanedione, a Specific Reagent of Arginyl Groups, Inactivates Sorghum NADP-MDH-Arginyl residue modification has been performed on activated sorghum NADP-MDH using various concentrations of butanedione in borate buffer, and residual activity was checked as a function of time. We thus found that NADP-MDH inactivation is time and -butanedione concentration-dependent and follows pseudo-first order inactivation kinetics (Fig. 1) . The double-logarithmic plot of the half times of inactivation against butanedione concentrations yielded the reaction order, n ϭ 1, (Fig. 2) . Thus, the loss of enzyme activity resulted from one molecule of butanedione binding per enzyme subunit. This suggests that modification of a single arginyl residue per subunit is sufficient for inactivation. Because DTT is a reducing agent and may react with butanedione, we performed the butanedione inactivation experiments in 5 mM or 250 M DTT final concentrations. We checked that the inactivation rate was affected proportional to the DTT concentration used but that the reaction order remained the same, independent of the DTT concentration used (data not shown), i.e. the number of modified residues was the same whatever the DTT concentration. A reciprocal plot of the observed rate constants (k app ) against butanedione concentrations gave a linear curve that started at the origin (Fig. 3) , suggesting that in these conditions, i.e. in borate/boric acid buffer, the derivatization was a simple bimolecular reaction (18) .
The AMP Moiety of NADPH Protects NADP-MDH from Inactivation by Butanedione-Pre-activated NADP-MDH inactivation by butanedione was performed in the presence of NADPH or AMP or nicotinamide (Fig. 4) . After a 30-min incubation with butanedione, samples containing NADPH were twice less inactivated by butanedione than control samples. Because NADPH is composed of an AMP moiety and a nicotinamide moiety, we performed a protection experiment using either one or the other of these two components. Nicotinamide did not protect, whereas AMP protected almost totally. The effect of AMP and nicotinamide was also checked in the reaction medium used to determine NADP-MDH activity. No effect was observed in the range of concentrations used (up to 120 M nicotinamide or AMP, taking in account the 100-fold dilution of the sample in the reaction cuvette). The AMP moiety of NADPH would thus be responsible for the protection against inactivation. These protection experiments suggest that the modified residue(s) would be located inside the active site at and/or close to the cofactor binding site.
Arg-134 and Arg-87 Are Modified by Butanedione-To directly identify which arginine residue was modified by butanedione, a large amount (10 nmols of monomer) of sorghum NADP-MDH was activated by thioredoxin and then treated with 4 mM butanedione. This sample exhibited a residual activity of 18% when compared with a control without butanedione. After removal of thioredoxin and excess reagent by a fast chromatographic step followed by extensive dialysis, the specific activity of butanedione-treated NADP-MDH corresponded to 22% of the control, indicating that the modification was irreversible. The two samples were then cleaved with trypsin, and the peptides were separated by reverse-phase HPLC. Two peptides specifically appeared in the tryptic profile of the treated sample (Fig. 5 ) and were further analyzed by Edman degradation sequencing and MALDI-TOF mass spectrometry (Table II) . Peptide 1 covered the sequence 109 -140, indicating that no tryptic cleavage could take place at Arg-134. Peptide 2 corresponded to the sequence 82-104, with no cleavage at Arg-87. On the contrary, the control sample was cleaved after these two Arg residues, generating smaller peptides that coeluted with other peptides. This experiment was performed three times and gave the same results, i.e. the specific presence of peptides 1 and 2 in the butanedione-treated sample with the same characteristics of sequence and mass. Thus we concluded that butanedione specifically targeted Arg-87 and Arg-134.
Direct evidence of chemical modification of Arg-87 was provided by Edman degradation of peptide 2 in which we sequenced the 15 first residues. Inside this sequence, the residue in position 87 failed to give any signal, whereas the other residues around Arg-87 gave high amounts of phenylthiohydantoin amino acid (from 80 to 50 pmol, data not shown). Such chemical evidence could not be obtained with peptide 1, due to the position of Arg-134 inside this peptide (27th residue) and the subsequent low amounts of phenylthiohydantoin amino acid recovered around this position. This suggests that the
FIG. 1. Effect of butanedione on sorghum NADP-MDH activity.
The activity of pre-activated sorghum NADP-MDH is represented as a function of incubation time with butanedione. Butanedione concentrations used were 0 mM (ϩ), 5 mM (E), 7.5 mM (Ⅺ), 10 mM (ࡗ), 12 mM (ϫ). Inactivation kinetics are plotted as semi-logarithmic curves, and the loss of activity follows a pseudo-first order kinetic.
FIG. 2. Determination of the reaction order of sorghum NADP-MDH inactivation by butanedione.
Logarithm of the half-time of inactivation against the logarithm of butanedione concentrations is represented and allows the calculation of the reaction order. The reaction order, which is representative of the average number of modified residues per subunit, corresponds to the value of the graph slope. Here, the slope ϭ 1. modification induced by butanedione is stable under Edman degradation sequencing or at least that the regeneration of arginine is prevented in these conditions. On the other hand, arginines were probably regenerated during MALDI-TOF analysis since mass spectrometry gave the expected masses of the peptides without modification. One can note that the product formed between butanedione and arginyl residue has never been isolated, even in the presence of borate buffer, which stabilizes this complex. It has been reported that derivatization by butanedione could be reversed at neutral pH when borate buffer was removed (17) . Butanedione-treated NADP-MDH was thus transferred into phosphate or Tris buffer after removal of thioredoxin. This sample was assayed for its residual specific activity and was then submitted to tryptic cleavage. The sample exhibited no activity, and its tryptic profile was identical to that of butanedione-treated NADP-MDH (data not shown). These results indicate that the reaction with butanedione was totally irreversible even after borate removal. This could be explained by the time needed for thioredoxin removal and extensive dialysis, as irreversible adducts could be formed after 1 h of incubation (17) .
R204K Activation Kinetics Is Less Sensitive to NADP-R204K-mutated protein had almost the same activation kinetics as the wild type enzyme (Fig. 6) . NADPϩ has been shown to strikingly slow down the activation kinetics of the WT NADP-MDH, probably by stabilizing the C-terminal extension inside the active site (20) . This property was tested for the R204K-mutated protein (Fig. 6) . The activation kinetics of R204K-mutated protein is much less slowed down in presence of NADPϩ than the WT enzyme kinetics.
R204K Mutation Modifies the Active Site Accessibility in the
Oxidized Enzyme-The accessibility of the active site in the unactivated forms of R134K-, R140Q-, or R204K-mutated MDH and WT MDH was tested by pretreating the oxidized enzymes with DEPC before starting the activation. When the active site is not accessible, the DEPC-pretreated enzymes can be fully activated. When it is accessible, the catalytic histidine is derivatized, and no subsequent activation can occur. The activation kinetics of these DEPC-pretreated enzymes are shown (Fig. 7) . The R134K, R140Q, and WT MDH activation was not impaired by pre-treatment with DEPC, indicating that R134K and R140Q mutations did not increase the accessibility of the active site in the oxidized enzymes. The R204K-mutated protein appeared to be activated to a much lesser extent after DEPC pretreatment, suggesting that R204K mutation increased the active site accessibility.
DISCUSSION
Arg-134 and Arg-204 Would Be Directly Involved in Oxalo-
acetate Binding-Structural data on NAD-MDH co-crystallized with citrate showed that arginines equivalent to Arg-134 and Arg-204 in sorghum NADP-MDH are involved in substrate binding (21) . In our study, site-directed mutagenesis experiments in which Arg-134 or Arg-204 positively charged arginyl residues were replaced by neutral glutamines yielded totally inactive mutated proteins. This complete loss of activity shows the importance of each of these arginines but does not allow us to discriminate between a structural or a functional effect of the mutation. Thus, mutated proteins in which either Arg-134 or Arg-204 were replaced by a lysine were engineered. Keeping a positive charge but replacing the guanidinium group of arginyl by a primary amine group of a lysyl yielded proteins exhibiting some activity upon activation by thioredoxins. The analysis of the kinetic parameters of the R204K-and R134K-mutated proteins showed that these two proteins are both drastically affected in their K m for OAA, and both exhibit strikingly altered overall catalytic efficiencies. The increase in K m values of R134K and R204K for OAA could be linked to an altered coordination of this substrate, as chemical properties of primary amine groups render these groups much less able to stabilize a carboxylate than would guanidinium. These results are clearly in favor of a direct involvement of Arg-134 and Arg-204 in oxaloacetate binding. Moreover, chemical modification experiments revealed R134K to be one of the two most reactive arginines of the active site, suggesting this residue to be particularly reactive and accessible. The k cat of the R134K-mutated protein is 10 times more affected than the k cat of the R204K protein compared with the wild-type enzyme. This suggests Arg-134 would be more involved in substrate activation for catalysis than Arg-204. Previous studies on NAD-MDH and lactate dehydrogenase pointed out the importance of the residue equivalent to Arg-134 of sorghum NADP-MDH in substrate specificity. Indeed replacing Gln-102 in Bacillus stearothermophilus lactate dehydrogenase, equivalent to Arg-81 in E. coli NAD-MDH and Arg-134 in sorghum NADP-MDH, by an arginine conferred on this mutated lactate dehydrogenase an efficient and highly specific malate dehydrogenase activity (10) . The corresponding mutant protein in E. coli NAD-MDH (mutation Arg-81Q) exhibited a reversed substrate specificity in favor of pyruvate, and its activity was altered compared with the wild-type enzyme (21) . In our study, no lactate dehydrogenase activity could be detected with the R134K-and the R134Q-mutated proteins. This observation underlines a surprising difference between NAD-and NADP-MDH. Arg-134 and its equivalents in E. coli NAD-MDH or B. stearothermophilus lactate dehydrogenase are located on a mobile loop of the active site. Residues equivalent to Arg-134 would have to come 
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closer to Arg-204 to bind pyruvate, which is smaller than OAA. We may notice that the residue in position 133 is a proline (Table III) , whereas the corresponding residues 80 in E. coli MDH and 101 in B. stearothermophilus lactate dehydrogenase are, respectively, an alanine and an asparagine. Pro-133 might rigidify the mobile loop in NADP-MDH compared with E. coli NAD-MDH or B. Stearothermophilus lactate dehydrogenase and prevent pyruvate coordination.
Role of Arg-140 -To investigate the role of Arg-140, the R140Q-mutated protein was engineered. Analysis of the kinetic parameters of R140Q protein revealed that the mutation affects oxaloacetate binding and catalytic efficiency. The drastic replacement of the positively charged arginine by a neutral glutamine does not inactivate the enzyme, as in the case of Arg-134 and Arg-204, but affects its K m OAA and catalytic efficiency. Compared with the results obtained for R134Q-and R204Q-mutated proteins, this result suggests that Arg-140 has an indirect role in OAA binding. Arg-140 is located at the N-terminal end of the ␣-helix next to the Arg-134-containing loop. This part of the protein is referred to as Arg 2 loop, and Arg-140 and Arg-134 are conserved residues in porcine cytosolic, E. coli, and Thermus flavus NAD-MDH and Flaveria, sorghum, and all the other chloroplastic NADP-MDHs (3). The structure of E. coli MDH co-crystallized with citrate clearly suggests that the arginine equivalent to Arg-140 would polarize the carbonyl group of OAA (21) . This hypothesis is consistent with both the increase of K m for OAA and decrease of catalytic efficiency in the R140Q-mutated protein. Our results would also be consistent with an effect of Arg-140 on the structurally close Arg-134; the positively charged Arg-140 may have an electrostatic orientation effect on Arg-134 and/or on the mobile loop.
Arg-204 Is Involved in the Blocking of the Active Site-In its oxidized state, NADP-MDH is inactive, and the C-terminal extension blocks the active site; the catalytic histidine cannot be derivatized by DEPC, a histidine-specific reagent (22) . Oxidized R204K-mutated protein is sensitive to DEPC, suggesting that in this mutant, the interaction of the C-terminal extension with the active site residues is loosened. This assumption is supported by the lower inhibition of activation of the R204K-mutated protein by NADPϩ compared with the wild type enzyme. Indeed, a previous study showed that the inhibition of activation by the oxidized cofactor could be accounted for by an improved stabilization of the C-terminal extension in the active site by the positively charged cofactor (20) . According to the x-ray structure, Arg-204 does not directly interact with the cofactor; thus, the loss of sensitivity of R204K-mutated protein to NADPϩ can be ascribed to a weaker interaction of the C-terminal extension in the active site. NADP-MDH crystal structure shows Arg-204 would be in direct interaction with the penultimate glutamate (Glu-388) of the C-terminal extension, Glu-388 carboxylate occupying partly the position of the substrate (2). This result underlines the drastic effect of such a discrete mutation, i.e. replacing an Arg with a Lys, both positively charged but with different chemical properties. Moreover, we can see that the activation kinetics of the R204K-mutated protein are very similar to those of the wild-type enzyme. As in the R204K mutant, the interaction with the C-terminal extension is loosened; this observation confirms that the rate-limiting step of NADP-MDH activation resides at the events occurring at the N terminus after the reduction of the N-terminal disulfide (23), i.e. the rearrangement between subunits and the shaping of the active site rather than the exclusion of the C-terminal extension from the active site.
Arg-87 Is Involved in Cofactor Binding-Chemical modification experiments show that Arg-87 and Arg-134 are the two most reactive arginines of the active site. Protection experiments using NADPH, AMP, and nicotinamide suggest that butanedione chemical modification affects an arginine that would be located at or close to the cofactor binding site area and, more precisely, an arginine involved in the fixation of the AMP moiety of the cofactor. According to the crystal structure of the oxidized Flaveria NADP-MDH co-crystallized with its cofactor, Arg-134 is not likely to be involved in cofactor binding. On the other hand, Arg-87 is located in a loop of the cofactor binding fold, which is accessible even in the oxidized enzyme. A recent study of the sorghum NADP-MDH cofactor binding site showed that (S85I/R87Q/S88A) mutation affects NADP-MDH cofactor specificity and enables the protein to use either NADPH or NADH as cofactor with the same affinity and efficiency (20) . Taken together, these results point out to the key role of Arg-87 in cofactor binding and recognition.
